FDA Approves Ultomiris

BOSTON–(BUSINESS WIRE)– December 21, 2018 — Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz), the first and only long-acting C5 complement inhibitor administered every eight weeks, for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a debilitating ultra-rare blood disorder characterized by complement-mediated destruction […]

Health Problems

Certain antibiotics tied to deadly heart vessel tears: FDA

(HealthDay)—Patients should avoid a class of antibiotics called fluoroquinolone due to an increased risk of heart vessel tears associated with their use, the U.S. Food and Drug Administration warned. “These tears, called aortic dissections, or ruptures of an aortic aneurysm can lead to dangerous bleeding or even death,” the agency said in a statement issued […]

Health News

FDA approves return of popular Primatene Mist asthma inhaler

A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It’s for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up. The original Primatene Mist was pulled from store shelves seven years ago […]